REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PT Kobayashi Pharmaceutical Indonesia (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: PT Kobayashi Pharmaceutical Indonesia Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Kobayashi Pharmaceutical Indonesia is a pharmaceutical company. It is a subsidiary of Kobayashi Pharmaceutical Co Ltd. The company manufactures pharmaceutical products, public goods, and cosmetics.

Headquarters
Karawaci Office Park - Ruko Excellis, No 19
Tangerang; Banten; Postal Code: 15139

Contact Details: Purchase the PT Kobayashi Pharmaceutical Indonesia report to view the information.

Website: http://www.kobayashi-id.com

Basic Information
Total Employees:
Purchase the PT Kobayashi Pharmaceutical Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Kobayashi Pharmaceutical Indonesia report to view the information.
Registered Capital:
Purchase the PT Kobayashi Pharmaceutical Indonesia report to view the information.
Incorporation Date:
March 13, 2012
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Kobayashi Pharmaceutical Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-0.26%▼
Total operating revenue
-0.26%▼
Total assets
0.67%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo